Research Article
Evaluation of Absolute Neutrophil Count in the Perioperative Setting of Sarcoma Resection
| | | N (%) |
| | Age at operation (years), median (IQR) | 36 (18–55.25) | | BMI at operation, median (IQR) | 25.61 (22.07–29.95) | | Sex | | Male | 59 (51.8) | | Female | 55 (48.2) | | Smoking history | 28 (24.6) | | Primary tumor type | | Ewing’s sarcoma | 13 (11.3) | | Undifferentiated pleomorphic sarcoma, bone | 5 (4.4) | | Leiomyosarcoma, bone | 5 (4.4) | | Osteosarcoma | 50 (43.9) | | Chondrosarcoma | 41 (36.0) | | Pathologic fracture | 17 (15.0) | | Metastases | 10 (8.8) | | Perioperative chemotherapy | 68 (59.6) | | Perioperative radiation | 23 (20.2) | | Preoperative ANC (thousand per μL), median (IQR) | 4.10 (2.58–6.00) | | Preoperative ALC (thousand per μL), median (IQR) | 1.62 (1.18–2.09) | | Salvage procedure | | Adult endoprosthesis | 48 (42.1) | | Expandable endoprosthesis | 2 (1.8) | | Allograft reconstruction | 25 (21.9) | | Autograft reconstruction | 3 (2.6) | | Rotationplasty | 2 (1.8) | | Resection or intralesional excision | 34 (29.8) |
|
|
IQR, interquartile range; BMI, body mass index; ANC, absolute neutrophil count; μL, microliter; ALC, absolute lymphocyte count.
|
